University of Thessaly (UTH)
Διερεύνηση της σχέσης μεταξύ retinol binding protein 4 και της αντίστασης στην ινσουλίνη στον αιμοκαθαιρόμενο πληθυσμό
Abstract
dc:descriptionIntroduction: The Retinol Binding Protein-4 (RBP-4) is a unique, special protein-carrier of retinol (vitamin A) in blood and until recently, the only known function was the transport of retinol in various tissues. Recent studies have shown that the RBP-4 seems to be involved in the onset of chronic inflammation and the development of insulin resistance. Insulin resistance and chronic inflammation are very common in patients with chronic conditions especially in those with end-stage kidney disease (CKD) receiving dialysis. However, it is not known whether the levels of RBP-4 are elevated in end stage renal disease (ESRD) patients and whether those levels are associated with factors involved in the development of insulin resistance.Purpose: The aim of the current study was to examine the levels of RBP-4 in hemodialysis patients and to explore the possibility of the association – if any - with insulin resistance. Methodology: Participants were identified among the patients with ESRD who were under a regular Hemodialysis (HD) program in the Renal Replacement Unit of Larissa University Hospital and “healthy” adult volunteers from the region of Thessaly. Volunteers in both groups had to fulfil all the inclusion criteria of this study. After providing written informed consent they participated in a series of tests to assess the aspects related to overall health, body composition, hormonal profile, haematological and biochemical parameters, the levels of insulin resistance by Homeostasis Model Assessment index Insulin Resistance Index (HOMA-IR) and the levels of RBP-4 in the blood. The study was approved by the local Ethical Committee at the University Hospital of Larissa and the University of Thessaly.Results: 35 HD patients (HD-group 12M/13F, 53.8 ± 18.1 years) and 27 healthy participants (CON-Group, 16M/11F, 52.1 ± 13.2 years) without any known kidney diseases and normal creatinine values. Τhe results showed that HD patients have significantly elevated levels of RBP-4 compared to the control group. The level of RBP-4 was not correlated significantly with the HOMA score, but only with fasting glucose, total cholesterol, iron levels, the thyroid and parathyroid hormone levels. HOMA-IR index was positively associated with anthropometric characteristics of the HD patients.Conclusions: The level of RBP-4 found to be elevated in the HD patients, while it seems that this protein is involved in metabolic pathways of chronic inflammation. However there is no strong evidence to denote any involvement of the levels of RBP-4 in the development of insulin resistance, as those assessed by the HOMA-IR index. In conclusion, the levels of RBP-4 have the potential to become an important factor for the evaluation of the metabolic profile of the HD patients and potentially be considered a supporting prognostic tool for monitoring the health of patients with chronic kidney diseases.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2017
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Papavasileiou, Vasileios
- Παπαβασιλείου, Βασίλειος
Subjects
dc:subject × 10Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/42412